-
Mashup Score: 7Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD - 9 month(s) ago
Key Points. Compared with classic acute GVHD, late acute GVHD presents with worse clinical severity and higher-risk biomarker parameters.Patients with late acut
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study - 9 month(s) ago
Key Points. An alemtuzumab population pharmacokinetic model has been developed for more accurate intravenous dosing in pediatric HSCT.Optimal exposure is associ
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
An alemtuzumab population pharmacokinetic model has been developed for more accurate intravenous dosing in pediatric HSCT. https://t.co/Ot1wgV6wFn #transplantation #clinicaltrialsandobservations https://t.co/SnuvuZLpB1
-
-
Mashup Score: 8Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD - 9 month(s) ago
Key Points. Unrelated-donor PBSCT with PTCY was associated with a reduced relapse rate compared with tacrolimus-based prophylaxis (25% vs 34%; P = .027).Moderat
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Unrelated-donor PBSCT with PTCY was associated with a reduced relapse rate compared with tacrolimus-based prophylaxis (25% vs 34%; P = .027). https://t.co/LFNg7NIszH #transplantation #clinicatrialsandobservations https://t.co/aRHt4K7YUt
-
-
Mashup Score: 4Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors - 9 month(s) ago
Key Points. Close integration of leukemia and HCT services and the use of haploidentical donors result in greater access to HCT than previously reported.Racial
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Close integration of leukemia and HCT services and the use of haploidentical donors result in greater access to HCT than previously reported. https://t.co/VsPg01bCqO #transplantation https://t.co/2jt4Z3a3sJ
-
-
Mashup Score: 0ISHLT: The International Society for Heart & Lung Transplantation - Call for Abstracts - 9 month(s) ago
Submit Your Best Science for ISHLT2024! Goran Dellgren, MD, PhD 2024 Scientific Program Chair On behalf of Jason Christie, MD, President of the International Society for Heart and Lung Transplantation, the ISHLT Board of Directors, and the ISHLT2024 Scientific Program Committee, I invite you to submit your research to be shared with peers at the Society’s 44th Annual Meeting & Scientific…
Source: ishlt.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Submit an abstract to #ISHLT2024! We want your science in the treatment of advanced #heart and #lung disease, #transplantation, #MCS/#LVAD, and #PVD. 🔗Learn more and get started here: https://t.co/kyE1YYT4RT https://t.co/g0C8RjyPSw
-
-
Mashup Score: 1Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect? - 9 month(s) ago
TO THE EDITOR:
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect? https://t.co/aNZRV3NSxG #commentary #clinicatrialsandobservations #myeloidneoplasia #transplantation
-
-
Mashup Score: 2Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia - 9 month(s) ago
Key Points. Time to transplant physician consult and allograft is delayed in non-European patients with AML.Cord blood facilitates rapid transplantation regardl
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Time to transplant physician consult and allograft is delayed in non-European patients with AML. https://t.co/ZO3JxBjIO4 #healthservicesandoutcomes #transplantation https://t.co/BSHth59f7q
-
-
Mashup Score: 1PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation - 10 month(s) ago
Key Points. CAST regimen is safe and effective in reducing acute GVHD after haploidentical peripheral blood transplantation.Our outcomes provide an impetus to f
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
CAST regimen is safe and effective in reducing acute GVHD after haploidentical peripheral blood transplantation. https://t.co/JdgwOSN9oI #transplantation https://t.co/j4iY2Xn7yy
-
-
Mashup Score: 1Selected memory T cells infused post–haploidentical hematopoietic stem cell transplantation persist and hyperexpand - 10 month(s) ago
Key Points. Infusions of donor memory T-cells after haplo-HSCT lead to engraftment, persistence, and prominent expansion of selected T-cell clones.Infused patie
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Infusions of donor memory T-cells after haplo-HSCT lead to engraftment, persistence, and prominent expansion of selected T-cell clones. https://t.co/Ts9P7prVHx #immunobiologyandimmunotherapy #transplantation https://t.co/oZlTDqbXop
-
-
Mashup Score: 1Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation - 10 month(s) ago
Key Points. Detectable pre-HCT MRD, even at a low level of <10–4, and any detectable post-HCT MRD increase the risk of post-HCT relapse.In B-cell ALL, detect
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Detectable pre-HCT MRD, even at a low level of <10–4, and any detectable post-HCT MRD increase the risk of post-HCT relapse. https://t.co/TXPHdSCj9I #clinicaltrialsandobservations #lymphoidneoplasia #transplantation https://t.co/FPPa1XXSAS
-
Compared with classic acute GVHD, late acute GVHD presents with worse clinical severity and higher-risk biomarker parameters. https://t.co/B29hVyuQvh #transplantation #clinicaltrialsandobservations #healtheservicesandoutcomes https://t.co/vImv0OBrhi